Triple Antibiotic
- Product NDC
- 11822-2700
- Requested package NDC
- 11822-2700-1
- 11-digit product format
- 118222700
- Labeler code
- 11822
- Product ID
- 11822-2700_e557c287-952a-4aa0-8fb0-2adae1650e6f
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bacitracin Zinc, Neomycin Sulfate, Polymyxin-B Sulfate, Pramoxine hydrochloride
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Rite Aid Corporation
- Application
- part333B
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-02-25
- Marketing end
- 0000-00-00
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
- Active strength
- 500 [iU]/g; mg/g; [USP'U]/g; mg/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11822-2700 | TRIPLE ANTIBIOTIC (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE, PRAMOXINE HYDROCHLORIDE) OINTMENT [RITE AID CORPORATION] | 4 | Legacy NDC | 20240514_c1c9bb83-4f79-4996-8019-9ee382bbf8c7.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11822-2700-1 | 11822270001 | 1 TUBE in 1 CARTON (11822-2700-1) > 28 g in 1 TUBE | 1 tube | 2022-02-25 | 0000-00-00 | No | No | Current |